Adrian Coles, PhD, is a seasoned biostatistician and drug developer with extensive experience in the pharmaceutical industry. They have held various roles, including Director of Biostatistics at Biogen since 2024 and previously at Bristol Myers Squibb, Eli Lilly and Company, and Duke Clinical Research Institute. Adrian's early research experience includes positions as a Graduate Research Assistant at The University of Texas MD Anderson Cancer Center and North Carolina State University. Additionally, they served in the United States Marine Corps from 1996 to 2005, where they led a team of over 40 Marines.
This person is not in the org chart
This person is not in any teams
This person is not in any offices